Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 14;6(12):e801. doi: 10.1097/HS9.0000000000000801

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

Figure 6. — Time to next treatment with acalabrutinib and IdR/BR. ^aBased on stratified Cox proportional hazards model, stratified by randomization stratification factors as recorded in interactive voice/web response system. ^bBased on stratified log-rank test, stratified by randomization stratification factors as recorded in interactive voice/web response system. BR = bendamustine plus rituximab; CI = confidence interval; HR = hazard ratio; IdR = idelalisib plus rituximab; NR = not reached; TTNT = time to next treatment.